Vascular Endothelial Growth Factor Transcriptional Activation Is Mediated by Hypoxia-inducible Factor 1α, HDM2, and p70S6K1 in Response to Phosphatidylinositol 3-Kinase/AKT Signaling
Open Access
- 1 October 2004
- journal article
- Published by Elsevier BV
- Vol. 279 (44), 45643-45651
- https://doi.org/10.1074/jbc.m404097200
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Vascular endothelial growth factor in ovarian cancerCurrent Oncology Reports, 1999
- Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant diseaseCancer, 1999
- Role of Vascular Endothelial Growth Factor in Ovarian Cancer: Inhibition of Ascites Formation by ImmunoneutralizationThe American Journal of Pathology, 1998
- Vascular endothelial growth factor serum concentrations in ovarian cancerObstetrics & Gynecology, 1998
- Expression of Angiogenesis-Related Genes and Progression of Human Ovarian Carcinomas in Nude MiceJNCI Journal of the National Cancer Institute, 1998
- Vascular endothelial growth factor expression in early stage ovarian carcinomaCancer, 1997
- Inhibition of Growth and Metastasis of Ovarian Carcinoma by Administering a Drug Capable of Interfering with Vascular Endothelial Growth Factor ActivityJapanese Journal of Cancer Research, 1996
- Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1Published by Elsevier BV ,1996
- Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 1995